Av. Magalhães de Castro, 4800
240 Floor Continental Tower Building Bairro Cidade Jardim
São Paulo, SP 05676-120
Brazil
https://www.hypera.com.br
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein: 10 301
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Breno Toledo Pires de Oliveira | CEO & Director | S.O. | S.O. | S.O. |
Mr. Adalmario Ghovatto Satheler do Couto | Investor Relations Officer & CFO | S.O. | S.O. | S.O. |
Mr. Carlos Roberto Scorsi | Chief Operating officer | S.O. | S.O. | 1962 |
Juliana Aguinaga Damião Salem | Senior Legal Officer & Director | S.O. | S.O. | S.O. |
Joao Felipe Khamis Aguilar | Risks & Compliance Officer | S.O. | S.O. | S.O. |
Mr. Luiz Eduardo Sales Clavis | VP of Sales and Marketing & Director | S.O. | S.O. | S.O. |
Mauricio Christovam | Senior Human Resources Officer | S.O. | S.O. | S.O. |
Mr. Hélio Segouras | Head of Consumer Health | S.O. | S.O. | S.O. |
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.
L’ISS Governance QualityScore de Hypera S.A. en date du 1 juin 2024 est 6. Les scores principaux sont Audit : 3; Société : 7; Droits des actionnaires : 1; Compensation : 8.